Details

Problem določitve meje v Piranskem zalivu : diplomsko delo
ID Imširović, Renata (Author), ID Debelak, Slavko (Mentor) More about this mentor... This link opens in a new window

.pdfPDF - Presentation file, Download (893,92 KB)
MD5: 91E0A8921C7B3C750D66AAD01EE780AD
PID: 20.500.12556/rul/6c92932f-fbbc-45d9-923f-3cfeab56a8a5

Language:Slovenian
Keywords:državna meja, Piranski zaliv, Republika Slovenija, Republika Hrvaška, mejna problematika, diplomske naloge
Work type:Bachelor thesis/paper
Typology:2.11 - Undergraduate Thesis
Organization:FU - Faculty of Administration
Place of publishing:Ljubljana
Publisher:[R. Imširović]
Year:2011
Number of pages:VII, 44 str.
PID:20.500.12556/RUL-21674 This link opens in a new window
UDC:341.222(043.2)
COBISS.SI-ID:3598254 This link opens in a new window
Publication date in RUL:11.07.2014
Views:2596
Downloads:376
Metadata:XML DC-XML DC-RDF
:
IMŠIROVIĆ, Renata, 2011, Problem določitve meje v Piranskem zalivu : diplomsko delo [online]. Bachelor’s thesis. Ljubljana : R. Imširović. [Accessed 24 March 2025]. Retrieved from: https://repozitorij.uni-lj.si/IzpisGradiva.php?lang=eng&id=21674
Copy citation
Share:Bookmark and Share

Similar documents

Similar works from RUL:
  1. Pomen tumorskih matičnih celic in epitelno-mezenhimskega prehoda pri napredovanju nedrobnoceličnega raka pljuč
  2. Gene expression levels of the prolyl hydroxylase domain proteins PHD1 and PHD2 but not PHD3 are decreased in primary tumours and correlate with poor prognosis of patients with surgically resected non-small-cell lung cancer
  3. Proučevanje izražanja gena za fosfatidiletanolamin-N-metiltransferazo v nedrobnoceličnem pljučnem rakavem tkivu
  4. Uporabnost imunohistokemičnega določanja mutacij receptorja za epidermalni rastni faktor pri raku pljuč
  5. Sladkorna bolezen in športna vadba
Similar works from other Slovenian collections:
  1. Expression patterns and prognostic relevance of subtype-specific transcription factors in surgically resected small cell lung cancer
  2. Outsourcing predictive biomarker testing in non-small cell carcinoma
  3. Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
  4. Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
  5. NSCLC molecular testing in Central and Eastern European countries

Back